Clinical Trials Browser

Phase 2 × Vancomycin × Clear all

NCT03785210 2026-02-23

Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers

Phase 2 Terminated

22 enrolled 13 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT04729322 2025-12-23

Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders

Phase 2 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

NCT05690048 2025-08-06

FLORA

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT04983901 2024-11-04

PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN

Phase 2 Completed

100 enrolled 38 charts

Other hematologic neoplasm

Hematologic Neoplasms

NCT03030248 2020-09-10

Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients

Phase 2 Completed

Clostridium Infections, Hematologic Diseases

NCT04025567 2020-03-16

Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) Oral

Phase 2 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular

NCT02732327 2017-07-21

Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer

Phase 2 Terminated

2 enrolled 2 charts

Classical hematology

Neoplasms, Febrile Neutropenia